Clinical and Radiographic Evaluation of Mineral Trioxide Aggregate and Biodentine as Pulp Medicaments in Primary Molars

NCT ID: NCT05102318

Last Updated: 2022-02-11

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

150 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-04-01

Study Completion Date

2022-09-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of the present study is to evaluate Mineral Trioxide Aggregate and Biodentine in direct pulp capping, partial pulpotomy, and pulpotomy in primary molars.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Screening of patients will continue until the target population is achieved. Identifying and recruiting potential subjects is achieved through patient database in Pediatric Dentistry department.

A total of 150 primary molars from healthy subjects will be selected from the Pediatric Dentistry and Dental Public Health outpatient clinic, Faculty of Dentistry, Ain shams University.

Subjects will be assigned randomly into two different treatment groups as follows:

MTA Group (1):

1. Group 1(A): MTA Direct Pulp Capping. (n=25)
2. Group 1 (B): MTA Partial Pulpotomy. (n=25)
3. Group 1 (C): MTA Complete Pulpotomy. (n=25)

BiodentineTM Group (2):

1. Group 2(A): BiodentineTM Direct Pulp Capping. (n=25)
2. Group 2 (B): BiodentineTM Partial Pulpotomy. (n=25)
3. Group 2 (C): BiodentineTM Complete Pulpotomy. (n=25)

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pulp Disease, Dental

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Direct Pulp Capping with Biodentine

Direct Pulp Capping with Biodentine

Group Type EXPERIMENTAL

Direct Pulp Capping

Intervention Type PROCEDURE

Direct Pulp Capping

Partial Pulpotomy with Biodentine

Partial Pulpotomy with Biodentine

Group Type EXPERIMENTAL

Partial Pulpotomy

Intervention Type PROCEDURE

Partial Pulpotomy

Pulpotomy with Biodentine

Pulpotomy with Biodentine

Group Type EXPERIMENTAL

Pulpotomy

Intervention Type PROCEDURE

Pulpotomy

Direct Pulp Capping with MTA

Direct Pulp Capping with MTA

Group Type EXPERIMENTAL

Direct Pulp Capping

Intervention Type PROCEDURE

Direct Pulp Capping

Partial Pulpotomy with MTA

Partial Pulpotomy with MTA

Group Type EXPERIMENTAL

Partial Pulpotomy

Intervention Type PROCEDURE

Partial Pulpotomy

Pulpotomy with MTA

Pulpotomy with MTA

Group Type EXPERIMENTAL

Pulpotomy

Intervention Type PROCEDURE

Pulpotomy

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Direct Pulp Capping

Direct Pulp Capping

Intervention Type PROCEDURE

Partial Pulpotomy

Partial Pulpotomy

Intervention Type PROCEDURE

Pulpotomy

Pulpotomy

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* No clinical symptoms or history implying irreversible pulpitis such as spontaneous pain, or pain persisting after stimuli removal.
* Absence of periapical or interadicular radiolucencies, inflammatory root resorption, sinus tract or gingival abscess.

Exclusion Criteria

* Children who are extremely uncooperative and difficult to manage.
* Children suffering from any physically or mentally disability that will complicate the treatment: Special Health Care needs (SHCN).
* Teeth of poor prognosis due to presence of an abscess or a sinus, mobility, advanced bone or root resorption or Non-Restorable teeth.
Minimum Eligible Age

4 Years

Maximum Eligible Age

7 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Ain Shams University

OTHER

Sponsor Role collaborator

British University In Egypt

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Marwa Magdy

Director

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Noha Kabil, Professor

Role: STUDY_DIRECTOR

British University In Egypt

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Ain Shams University

Cairo, , Egypt

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Marwa Magdy, PhD

Role: CONTACT

00201007195996

Nadia Metwalli, Professor

Role: CONTACT

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Marwa Magdy, PhD

Role: primary

00201007195996

Nadia Metwalli, Professor

Role: backup

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Ain Shams University

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

3Mixtatin and MTA Vital Pulpotomy in Primary Molars
NCT06478940 NOT_YET_RECRUITING PHASE1
New Vital Pulpotomy Medications in Primary Molars
NCT05937100 ACTIVE_NOT_RECRUITING NA